<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
		>
<channel>
	<title>Comments on: Why are biogenerics so hard to regulate?</title>
	<atom:link href="http://www.biotechblog.com/2007/03/05/why-are-biogenerics-so-hard-to-regulate/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.biotechblog.com/2007/03/05/why-are-biogenerics-so-hard-to-regulate/</link>
	<description>Commercial, legal, political, and scientific trends in biotechnology</description>
	<lastBuildDate>Thu, 09 Feb 2012 15:32:22 +0000</lastBuildDate>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=3.3</generator>
	<item>
		<title>By: satishkumar.N</title>
		<link>http://www.biotechblog.com/2007/03/05/why-are-biogenerics-so-hard-to-regulate/comment-page-1/#comment-12528</link>
		<dc:creator>satishkumar.N</dc:creator>
		<pubDate>Tue, 22 Mar 2011 18:35:07 +0000</pubDate>
		<guid isPermaLink="false">http://www.biotechblog.com/2007/03/05/why-are-biogenerics-so-hard-to-regulate/#comment-12528</guid>
		<description>with out any approval  for biogenerics how can one trust that they are safe to use?what about the cost factor for biogenerics will a normal man can afford its price?</description>
		<content:encoded><![CDATA[<p>with out any approval  for biogenerics how can one trust that they are safe to use?what about the cost factor for biogenerics will a normal man can afford its price?</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: eda</title>
		<link>http://www.biotechblog.com/2007/03/05/why-are-biogenerics-so-hard-to-regulate/comment-page-1/#comment-6863</link>
		<dc:creator>eda</dc:creator>
		<pubDate>Tue, 23 Sep 2008 15:39:55 +0000</pubDate>
		<guid isPermaLink="false">http://www.biotechblog.com/2007/03/05/why-are-biogenerics-so-hard-to-regulate/#comment-6863</guid>
		<description>wat r diferent between biogenerics and biosimilar...help me ....</description>
		<content:encoded><![CDATA[<p>wat r diferent between biogenerics and biosimilar&#8230;help me &#8230;.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: When will the U.S. develop concise generic biologic rules? &#124; Biotech Blog</title>
		<link>http://www.biotechblog.com/2007/03/05/why-are-biogenerics-so-hard-to-regulate/comment-page-1/#comment-6862</link>
		<dc:creator>When will the U.S. develop concise generic biologic rules? &#124; Biotech Blog</dc:creator>
		<pubDate>Mon, 22 Sep 2008 19:06:04 +0000</pubDate>
		<guid isPermaLink="false">http://www.biotechblog.com/2007/03/05/why-are-biogenerics-so-hard-to-regulate/#comment-6862</guid>
		<description>[...] I’ve described before,  regulating generic biologics is no easy feat. A good regulatory scheme must address safety issues while enabling productive competition. Failure [...]</description>
		<content:encoded><![CDATA[<p>[...] I’ve described before,  regulating generic biologics is no easy feat. A good regulatory scheme must address safety issues while enabling productive competition. Failure [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Patent Baristas &#187; Can Approval of Biogenerics Really Save Money?</title>
		<link>http://www.biotechblog.com/2007/03/05/why-are-biogenerics-so-hard-to-regulate/comment-page-1/#comment-5702</link>
		<dc:creator>Patent Baristas &#187; Can Approval of Biogenerics Really Save Money?</dc:creator>
		<pubDate>Tue, 19 Feb 2008 16:48:53 +0000</pubDate>
		<guid isPermaLink="false">http://www.biotechblog.com/2007/03/05/why-are-biogenerics-so-hard-to-regulate/#comment-5702</guid>
		<description>[...] See also:  Why are biogenerics so hard to regulate? [...]</description>
		<content:encoded><![CDATA[<p>[...] See also:  Why are biogenerics so hard to regulate? [...]</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: smaranya.com &#187; An appeal for generic biologic legislation</title>
		<link>http://www.biotechblog.com/2007/03/05/why-are-biogenerics-so-hard-to-regulate/comment-page-1/#comment-5673</link>
		<dc:creator>smaranya.com &#187; An appeal for generic biologic legislation</dc:creator>
		<pubDate>Mon, 11 Feb 2008 01:35:07 +0000</pubDate>
		<guid isPermaLink="false">http://www.biotechblog.com/2007/03/05/why-are-biogenerics-so-hard-to-regulate/#comment-5673</guid>
		<description>[...] posted previously on the challenges of developing a framework for generic biologic approvals and questioned how much we can really expect to save. In the [...]</description>
		<content:encoded><![CDATA[<p>[...] posted previously on the challenges of developing a framework for generic biologic approvals and questioned how much we can really expect to save. In the [...]</p>
]]></content:encoded>
	</item>
</channel>
</rss>

